White Falcon Capital's Q1 2025 letter discusses their take on tariffs, provides a portfolio update, and presents an ...

Now he hopes to help guide Iraq’s industry ... the pharma sector grew out of these donations and I became a consultant to SmithKline Beecham and the newly-formed Zeneca.” The situation in ...

Despite the market punishing Grifols, we believe that this presents a buying opportunity. Click here for our investment ...

In the life sciences industry in particular, leading pharma companies are already deploying this technology across their own operations to spur productivity and efficiency for mundane, time ...